EP Patent

EP2214677A2 — Compositions for the treatment of inflammation of the gastrointestinal tract

Assigned to Meritage Pharma Inc · Expires 2010-08-11 · 16y expired

What this patent protects

Provided herein are methods for treating the symptoms of and inflammation associated with gastroesophageal reflux disease (GERD) and other conditions. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.

USPTO Abstract

Provided herein are methods for treating the symptoms of and inflammation associated with gastroesophageal reflux disease (GERD) and other conditions. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.

Drugs covered by this patent

Patent Metadata

Patent number
EP2214677A2
Jurisdiction
EP
Classification
—
Expires
2010-08-11
Drug substance claim
No
Drug product claim
No
Assignee
Meritage Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.